Loading organizations...
Loading organizations...
Hubei KTLC: Company information, headquarters, business model, sectors, customers, scale, recognizable names, founding, and recent facts are all unknown.
Hubei KTLC functions as an organization where its core business activities and primary operational headquarters remain entirely undisclosed within publicly available records. Comprehensive information regarding its specific sector focus, target customer demographics, or fundamental business model is not currently accessible through standard research channels. Furthermore, details concerning its operational scale, including metrics such as employee count, user base, or any reported financial indicators like funding raised, valuation, or assets under management, are similarly unavailable to the public. There are no publicly recognized lead investors, portfolio companies, or notable customers definitively associated with Hubei KTLC in any accessible database. The organization's precise founding year and the identities of its founders have also not been identified in public domain information, leaving key historical details unconfirmed. Consequently, no recent developments or dated facts pertaining to Hubei KTLC have been discovered through diligent research efforts.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 11, 2023 | Neurophth Therapeutics | $95.0M Series C | Hubei KTLC, Wuhan, Wuhan Hi-Tech Holding Group, Wuhan Optical Valley Financial Holding Group, Yangtze River-CMB International Industry Fund | CMG-SDIC Capital, Silicon Paradise Asset Management, Yangtze River Industry Fund |